Premium
P2‐143: Method Comparison of AB(1‐42) Measured in Human Cerebrospinal Fluid Samples by Liquid Chromatography‐Tandem Mass Spectrometry, the Inno‐Bia ALZBIO3 Assay, and the Elecsys ® B‐Amyloid(1‐42) Assay
Author(s) -
Shaw Leslie M.,
Fields Leona,
Korecka Magdalena,
Waligórska Teresa,
Trojanowski John Q.,
Allegranza Deirdre,
Bittner Tobias,
He Ying,
Morgan Kelly,
Rabe Christina
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.1513
Subject(s) - chromatography , immunoassay , chemistry , tandem mass spectrometry , cerebrospinal fluid , analyte , liquid chromatography–mass spectrometry , mass spectrometry , medicine , pathology , immunology , antibody
INHUMANCEREBROSPINALFLUID SAMPLESBY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, THE INNO-BIA ALZBIO3 ASSAY, AND THE ELECSYS B-AMYLOID(1-42) ASSAY LeslieM. Shaw, Leona Fields, Magdalena Korecka, TeresaWalig orska, John Q. Trojanowski, Deirdre Allegranza, Tobias Bittner, Ying He, Kelly Morgan, Christina Rabe, University of Pennsylvania Hospital, Philadelphia, PA, USA; 2 Roche Diagnostics International AG, Rotkreuz, Switzerland; 3 Roche Diagnostics GmbH, Penzberg, Germany; 4 Roche Diagnostics Corporation, Indianapolis, IN, USA. Contact e-mail: Les. Shaw@uphs.upenn.edu